ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.
about
SWI/SNF chromatin remodeling complexes and cancerDeletion of Arid1a in Reproductive Tract Mesenchymal Cells Reduces Fertility in Female Mice.A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationThe UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer.Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.The emerging roles of ARID1A in tumor suppression.Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation.Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.The diagnostic role of PTEN and ARID1A in serous effusions.Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract.Unmasking molecular profiles of bladder cancer.New therapeutic options opened by the molecular classification of gastric cancer.ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
P2860
Q26998657-BB3E60F3-11C2-49CD-B05F-7963395D2C69Q30353348-3F80E5AD-DAB9-4E13-A3FE-CDC55F0A93C1Q35100056-0F54ECE8-9080-45F2-B996-343432DB850CQ35638497-A6AC8DCA-1031-46FE-8433-89AF45620EA1Q36441526-5C07C779-03D5-4FE5-92C3-DE177149FB40Q37341453-D721FBFB-7B1F-4387-B53E-B9E5ACF80AD4Q38195175-E09C54C5-4B88-48A2-B94D-4743421FF6FCQ38379487-23FDF6A1-0C31-42A5-AD5C-C47E378BD0B1Q38627721-C5757B1E-6F24-403D-B100-3A682AAE8287Q39352697-7E9F3195-621F-48F5-887A-21CC6E900CC2Q40275671-8514DB36-961C-4194-B1E6-A3BECB3703EBQ47369086-0D7C8625-6B16-4F8B-BD7A-1C32210A23E2Q51684531-CFD50827-7812-4064-A632-58C68CBAA331Q55427566-E29FDFC5-5212-4910-B98F-264C675AE7EFQ55527185-76A92338-D76F-42EF-8E12-2B3DAB3DC118Q57167864-36ABF755-0D69-464F-A406-744E24A72F5C
P2860
ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@ast
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@en
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@nl
type
label
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@ast
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@en
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@nl
prefLabel
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@ast
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@en
ARID1A alterations are associa ...... is, urothelial bladder tumors.
@nl
P2093
P2860
P50
P1433
P1476
ARID1A alterations are associa ...... sis, urothelial bladder tumors
@en
P2093
Ariel Casanova
Cristina Balbás-Martínez
Gonzalo Gómez
Josep Lloreta
José A Lorente
María Rodríguez-Pinilla
Orlando Domínguez
P2860
P304
P356
10.1371/JOURNAL.PONE.0062483
P407
P577
2013-05-01T00:00:00Z